Results 261 to 270 of about 87,116 (304)

Ultrasound elastography for the differential diagnosis of benign and malignant gastrointestinal stromal tumors. [PDF]

World J Gastrointest Surg
Xu H, Liu JR, Gao BJ, Peng L, Han ZQ, Zhang RX.   +5 more
europepmc   +1 more source

Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in gastrointestinal stromal tumors after imatinib targeted therapy. [PDF]

Theranostics
Tao P, Wang J, Fan P, Liu W, Lu W, Hu Y, Lu Q, Ma L, Tong H, Zhang Y.   +9 more
europepmc   +1 more source

Interpretable deep learning model diagnoses gastrointestinal stromal tumors and lesion characteristics with microprobe endoscopic ultrasonography. [PDF]

Sci Rep
Li J, Jing X, Zhang Q, Wang X, Wang L, Shan J, Zhou Z, Jiang D, Yan Y, Liu L, Zhao M, Fan L, Zheng C, Gong X, Sun X.   +14 more
europepmc   +1 more source

A novel method of synchronous closure for endoscopic full-thickness resection of exophytic gastrointestinal stromal tumors. [PDF]

Endoscopy
Jiang J, Ma Q, Ye L, Sun R, Sun Z, Xu L, Pan F.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gastrointestinal stromal tumors

Abdominal Imaging, 2006
We reviewed radiologic features of gastrointestinal stromal tumors (GISTs) and correlated them with clinical and pathologic findings.We investigated a series of 39 c-Kit-positive GISTs. Clinical and radiologic findings and management of these patients were recorded.Twenty women and 19 men (mean age 64 years) had histologically proved GIST.
A, Darnell, E, Dalmau, C, Pericay, E, Musulén, J, Martín, J, Puig, A, Malet, E, Saigí, M, Rey   +8 more
openaire   +4 more sources

Gastrointestinal stromal tumor

Surgical Oncology, 2008
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These form a distinct category of tumors characterized by oncogenic mutations of the KIT receptor tyrosine kinase in a majority of patients. KIT is used not only for diagnosis but also for targeted therapy of GISTs.
Puneet, Gupta, Mallika, Tewari, Hari S, Shukla   +2 more
openaire   +2 more sources

Gastrointestinal Stromal Tumors

Hematology/Oncology Clinics of North America, 2005
Gastrointestinal stromal tumors (GISTs) are identified pathologically by the expression of KIT. The management of GISTs has been altered significantly by the development of imatinib mesylate, a tyrosine kinase inhibitor with activity against KIT and platelet-derived growth factor receptors.
Margaret, von Mehren, James C, Watson
openaire   +2 more sources

RETROVESICAL GASTROINTESTINAL STROMAL TUMOR

Journal of Urology, 2001
Primitive mesenchymal gastrointestinal tumors without evidence of differentiation are referred to as gastrointestinal stromal tumors. Because gastrointestinal stromal tumors are known for their wide variability in clinical behavior and for the difficulty in determining their malignant potential, numerous studies have been done to define better useful ...
Y S, Lee, K, Sakamoto, J G, Blaivas, A, Chu   +3 more
openaire   +2 more sources

GASTROINTESTINAL STROMAL TUMOR

2010
Gastrointestinal stromal tumor, i.e., GIST is by far the most common mesenchymal tumor of the gastrointestinal tract. GIST has received special clinical attention, because it is one of the first solid tumors treated with tyrosine kinase inhibitors as targeted oncological therapy.
openaire   +2 more sources